1. Homepage
  2. Equities
  3. Finland
  4. Nasdaq Helsinki
  5. Nanoform Finland Oyj
  6. News
  7. Summary
    NANOFH   FI4000330972

NANOFORM FINLAND OYJ

(NANOFH)
  Report
Delayed Nasdaq Helsinki  -  11:03 2022-07-01 am EDT
3.480 EUR   -1.00%
06/13Nanoform Chief of Business Operations Gonçalo Andrade steps down
AQ
06/13Nanoform's Gonçalo Andrade Steps Down as Chief of Business Operations
CI
06/13Nanoform Finland Plc - Manager's transactions - Jeanne Thoma
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Nanoform Finland Plc. Launches "STARMAP® Online" Placing AI-Power at the Fingertips of Medicine Developers

05/04/2022 | 02:35am EDT

Nanoform Finland plc announced that it has launched its sparse-data AI solution (STARMAP® Online) as a secure online portal for direct use by its current and future partners. Since its inception in 2020, STARMAP® has been actively used by Nanoform to provide its clients with a confident assessment of their molecules' suitability for Controlled Expansion of Supercritical Solutions (CESS®) nanoparticle engineering. STARMAP® is a digital version of the CESS® technology that enables in silico experiments to determine which molecules should be nanoformed. Nanoform's legacy processes involved handling all analyses in-house after receiving specific molecule attributes from its clients. STARMAP® Online has been launched as a direct request from Nanoform's current and future partners who seek to maintain the level of confidence STARMAP® offers, while integrating it into their own in-house molecule-selection processes. STARMAP® Online creates the opportunity for clients to perform large numbers of in-silico CESS® experiments from their desktop, prior to approaching Nanoform to perform experimental validation. This approach further supports Nanoform's green ambition by ensuring that Nanoform progresses the molecules with the greatest probability of success. STARMAP® Online offers increased user confidence through: Security and safety - the interface has been developed in alignment with ISO27001:2017 standards. Client submissions are seen only by clients (not by Nanoform), allowing molecules to be screened without sharing structures. Outputs are presented directly to the client via the system. Scalability and agility: The ability to manage thousands of molecules in a single submission to support the selection of candidates from molecule libraries is possible. Novel insights: STARMAP® Online holds a database of over 17,000 pre-analyzed, public-domain disclosed drugs and candidates. Clients can request thematic evaluations and understand the power of CESS® in different therapeutic areas, target classes, and disease areas.


© S&P Capital IQ 2022
All news about NANOFORM FINLAND OYJ
06/13Nanoform Chief of Business Operations Gonçalo Andrade steps down
AQ
06/13Nanoform's Gonçalo Andrade Steps Down as Chief of Business Operations
CI
06/13Nanoform Finland Plc - Manager's transactions - Jeanne Thoma
AQ
06/13Nanoform Finland Plc - Manager's transactions - Albert Hæggström
AQ
06/13Nanoform Finland Plc - Manager's transactions - Mads Laustsen
AQ
06/06Share subscriptions based on Nanoform Finland Plc's stock options 1-2/2019 and 1/2020
AQ
06/06The Board of Directors of Nanoform Finland Plc decided on issue of stock options to key..
AQ
06/06Nanoform Finland Plc - Manager's transactions - Miguel Calado
AQ
06/02NANOFORM FINLAND OYJ : Plc – Manager's transactions – Niklas Sandler
PU
06/02Nanoform Finland Plc - Manager's transactions - Niklas Sandler
AQ
More news
Financials
Sales 2022 7,00 M 7,28 M 7,28 M
Net income 2022 -18,7 M -19,5 M -19,5 M
Net cash 2022 74,4 M 77,4 M 77,4 M
P/E ratio 2022 -13,9x
Yield 2022 -
Capitalization 273 M 283 M 283 M
EV / Sales 2022 28,3x
EV / Sales 2023 10,9x
Nbr of Employees 130
Free-Float 74,7%
Chart NANOFORM FINLAND OYJ
Duration : Period :
Nanoform Finland Oyj Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NANOFORM FINLAND OYJ
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 3,48 €
Average target price 8,88 €
Spread / Average Target 155%
EPS Revisions
Managers and Directors
Edward Hæggström Chief Executive Officer
Albert Häggström Chief Financial Officer & Director
Miguel Maria de Oliveira Barreiros Calado Chairman
Niklas Sandler Chief Technology Officer
Gonçalo Nuno N. da Silva Rebelo de Andrade Chief Business Operations
Sector and Competitors
1st jan.Capi. (M$)
NANOFORM FINLAND OYJ-47.11%283
JOHNSON & JOHNSON3.76%472 389
PFIZER, INC.-11.21%293 506
ELI LILLY AND COMPANY17.38%292 291
ROCHE HOLDING AG-15.48%272 104
ABBVIE INC.13.59%271 782